The hub genes of these modules, for example CTAG2, MAGEA6, MAGEA1, GABRA3, HTR2C, NEK2, KIF14, CENPF, and RRM2 could be explored further as new therapeutic targets or predictive clinical markers of MM outcomes. The gene discussed is CTAG2; the disease is Miyoshi myopathy.